Global Dapagliflozin and Metformin Extended-Release Tablets Supply, Demand and Key Producers, 2026-2032
The global Dapagliflozin and Metformin Extended-Release Tablets market size is expected to reach $ 1681 million by 2032, rising at a market growth of 14.8% CAGR during the forecast period (2026-2032).
In 2025, global Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets production reached approximately 12.5 million units.Dapagliflozin and Metformin Extended-Release Tablets are a combination oral hypoglycemic drug primarily used to treat type 2 diabetes. This medication combines dapagliflozin (an SGLT-2 inhibitor) and metformin (a classic oral hypoglycemic drug), working synergistically. Dapagliflozin reduces blood glucose levels by inhibiting the kidney's reabsorption of glucose, while metformin helps control blood glucose by improving insulin sensitivity and reducing hepatic glucose production. The extended-release tablet formulation allows for the gradual release of the drug over time, minimizing side effects and enhancing patient adherence to the treatment. It is suitable for long-term blood glucose control in patients with type 2 diabetes.
Dapagliflozin and Metformin Extended-Release Tablets, as a novel combination hypoglycemic drug, demonstrate significant market potential in the treatment of type 2 diabetes due to its innovative combination therapy and extended-release technology. With the growing global prevalence of diabetes, especially in aging societies, the demand for diabetes medications continues to rise. Dapagliflozin helps patients effectively control blood glucose by inhibiting the SGLT-2 transporter, while metformin provides a dual glucose-lowering effect by improving insulin sensitivity and reducing hepatic glucose production.
The extended-release formulation of dapagliflozin and metformin offers better tolerance and fewer side effects, improving patient adherence, which is crucial for the long-term management of diabetes. Additionally, with the advancement of precision medicine, the demand for personalized treatments is increasing, and combination drugs like dapagliflozin and metformin extended-release tablets are better able to meet the diverse needs of patients.
This report studies the global Dapagliflozin and Metformin Extended-Release Tablets production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Dapagliflozin and Metformin Extended-Release Tablets and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dapagliflozin and Metformin Extended-Release Tablets that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Dapagliflozin and Metformin Extended-Release Tablets total production and demand, 2021-2032, (Units)
Global Dapagliflozin and Metformin Extended-Release Tablets total production value, 2021-2032, (USD Million)
Global Dapagliflozin and Metformin Extended-Release Tablets production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Dapagliflozin and Metformin Extended-Release Tablets consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Dapagliflozin and Metformin Extended-Release Tablets domestic production, consumption, key domestic manufacturers and share
Global Dapagliflozin and Metformin Extended-Release Tablets production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Dapagliflozin and Metformin Extended-Release Tablets production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Dapagliflozin and Metformin Extended-Release Tablets production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Dapagliflozin and Metformin Extended-Release Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Merck, Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dapagliflozin and Metformin Extended-Release Tablets market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Dapagliflozin and Metformin Extended-Release Tablets Market, By Region:
1. How big is the global Dapagliflozin and Metformin Extended-Release Tablets market?
2. What is the demand of the global Dapagliflozin and Metformin Extended-Release Tablets market?
3. What is the year over year growth of the global Dapagliflozin and Metformin Extended-Release Tablets market?
4. What is the production and production value of the global Dapagliflozin and Metformin Extended-Release Tablets market?
5. Who are the key producers in the global Dapagliflozin and Metformin Extended-Release Tablets market?
6. What are the growth factors driving the market demand?
In 2025, global Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets production reached approximately 12.5 million units.Dapagliflozin and Metformin Extended-Release Tablets are a combination oral hypoglycemic drug primarily used to treat type 2 diabetes. This medication combines dapagliflozin (an SGLT-2 inhibitor) and metformin (a classic oral hypoglycemic drug), working synergistically. Dapagliflozin reduces blood glucose levels by inhibiting the kidney's reabsorption of glucose, while metformin helps control blood glucose by improving insulin sensitivity and reducing hepatic glucose production. The extended-release tablet formulation allows for the gradual release of the drug over time, minimizing side effects and enhancing patient adherence to the treatment. It is suitable for long-term blood glucose control in patients with type 2 diabetes.
Dapagliflozin and Metformin Extended-Release Tablets, as a novel combination hypoglycemic drug, demonstrate significant market potential in the treatment of type 2 diabetes due to its innovative combination therapy and extended-release technology. With the growing global prevalence of diabetes, especially in aging societies, the demand for diabetes medications continues to rise. Dapagliflozin helps patients effectively control blood glucose by inhibiting the SGLT-2 transporter, while metformin provides a dual glucose-lowering effect by improving insulin sensitivity and reducing hepatic glucose production.
The extended-release formulation of dapagliflozin and metformin offers better tolerance and fewer side effects, improving patient adherence, which is crucial for the long-term management of diabetes. Additionally, with the advancement of precision medicine, the demand for personalized treatments is increasing, and combination drugs like dapagliflozin and metformin extended-release tablets are better able to meet the diverse needs of patients.
This report studies the global Dapagliflozin and Metformin Extended-Release Tablets production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Dapagliflozin and Metformin Extended-Release Tablets and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dapagliflozin and Metformin Extended-Release Tablets that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Dapagliflozin and Metformin Extended-Release Tablets total production and demand, 2021-2032, (Units)
Global Dapagliflozin and Metformin Extended-Release Tablets total production value, 2021-2032, (USD Million)
Global Dapagliflozin and Metformin Extended-Release Tablets production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Dapagliflozin and Metformin Extended-Release Tablets consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Dapagliflozin and Metformin Extended-Release Tablets domestic production, consumption, key domestic manufacturers and share
Global Dapagliflozin and Metformin Extended-Release Tablets production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Dapagliflozin and Metformin Extended-Release Tablets production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Dapagliflozin and Metformin Extended-Release Tablets production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Dapagliflozin and Metformin Extended-Release Tablets market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Merck, Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dapagliflozin and Metformin Extended-Release Tablets market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Dapagliflozin and Metformin Extended-Release Tablets Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 10mg/1000mg
- 5mg + 500mg
- Innovator
- Generic
- Extended-release tablet
- Conventional Tablet
- Type 2 Diabetes
- Weight Management
- Cardiovascular
- Others
- AstraZeneca
- Merck
- Pfizer
1. How big is the global Dapagliflozin and Metformin Extended-Release Tablets market?
2. What is the demand of the global Dapagliflozin and Metformin Extended-Release Tablets market?
3. What is the year over year growth of the global Dapagliflozin and Metformin Extended-Release Tablets market?
4. What is the production and production value of the global Dapagliflozin and Metformin Extended-Release Tablets market?
5. Who are the key producers in the global Dapagliflozin and Metformin Extended-Release Tablets market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Dapagliflozin and Metformin Extended-Release Tablets Introduction
1.2 World Dapagliflozin and Metformin Extended-Release Tablets Supply & Forecast
1.2.1 World Dapagliflozin and Metformin Extended-Release Tablets Production Value (2021 & 2025 & 2032)
1.2.2 World Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2032)
1.2.3 World Dapagliflozin and Metformin Extended-Release Tablets Pricing Trends (2021-2032)
1.3 World Dapagliflozin and Metformin Extended-Release Tablets Production by Region (Based on Production Site)
1.3.1 World Dapagliflozin and Metformin Extended-Release Tablets Production Value by Region (2021-2032)
1.3.2 World Dapagliflozin and Metformin Extended-Release Tablets Production by Region (2021-2032)
1.3.3 World Dapagliflozin and Metformin Extended-Release Tablets Average Price by Region (2021-2032)
1.3.4 North America Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2032)
1.3.5 Europe Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2032)
1.3.6 China Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2032)
1.3.7 Japan Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2032)
1.3.8 India Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Dapagliflozin and Metformin Extended-Release Tablets Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Dapagliflozin and Metformin Extended-Release Tablets Major Market Trends
2 DEMAND SUMMARY
2.1 World Dapagliflozin and Metformin Extended-Release Tablets Demand (2021-2032)
2.2 World Dapagliflozin and Metformin Extended-Release Tablets Consumption by Region
2.2.1 World Dapagliflozin and Metformin Extended-Release Tablets Consumption by Region (2021-2026)
2.2.2 World Dapagliflozin and Metformin Extended-Release Tablets Consumption Forecast by Region (2027-2032)
2.3 United States Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
2.4 China Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
2.5 Europe Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
2.6 Japan Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
2.7 South Korea Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
2.8 ASEAN Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
2.9 India Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Dapagliflozin and Metformin Extended-Release Tablets Production Value by Manufacturer (2021-2026)
3.2 World Dapagliflozin and Metformin Extended-Release Tablets Production by Manufacturer (2021-2026)
3.3 World Dapagliflozin and Metformin Extended-Release Tablets Average Price by Manufacturer (2021-2026)
3.4 Dapagliflozin and Metformin Extended-Release Tablets Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Dapagliflozin and Metformin Extended-Release Tablets Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Dapagliflozin and Metformin Extended-Release Tablets in 2025
3.5.3 Global Concentration Ratios (CR8) for Dapagliflozin and Metformin Extended-Release Tablets in 2025
3.6 Dapagliflozin and Metformin Extended-Release Tablets Market: Overall Company Footprint Analysis
3.6.1 Dapagliflozin and Metformin Extended-Release Tablets Market: Region Footprint
3.6.2 Dapagliflozin and Metformin Extended-Release Tablets Market: Company Product Type Footprint
3.6.3 Dapagliflozin and Metformin Extended-Release Tablets Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Production Value Comparison
4.1.1 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Production Comparison
4.2.1 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Consumption Comparison
4.3.1 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Dapagliflozin and Metformin Extended-Release Tablets Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Dapagliflozin and Metformin Extended-Release Tablets Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Dapagliflozin and Metformin Extended-Release Tablets Production Value (2021-2026)
4.4.3 United States Based Manufacturers Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2026)
4.5 China Based Dapagliflozin and Metformin Extended-Release Tablets Manufacturers and Market Share
4.5.1 China Based Dapagliflozin and Metformin Extended-Release Tablets Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Dapagliflozin and Metformin Extended-Release Tablets Production Value (2021-2026)
4.5.3 China Based Manufacturers Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2026)
4.6 Rest of World Based Dapagliflozin and Metformin Extended-Release Tablets Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Dapagliflozin and Metformin Extended-Release Tablets Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-Release Tablets Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Dapagliflozin and Metformin Extended-Release Tablets Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 10mg/1000mg
5.2.2 5mg + 500mg
5.3 Market Segment by Type
5.3.1 World Dapagliflozin and Metformin Extended-Release Tablets Production by Type (2021-2032)
5.3.2 World Dapagliflozin and Metformin Extended-Release Tablets Production Value by Type (2021-2032)
5.3.3 World Dapagliflozin and Metformin Extended-Release Tablets Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
6.1 World Dapagliflozin and Metformin Extended-Release Tablets Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Production Technology
6.2.1 Innovator
6.2.2 Generic
6.3 Market Segment by Production Technology
6.3.1 World Dapagliflozin and Metformin Extended-Release Tablets Production by Production Technology (2021-2032)
6.3.2 World Dapagliflozin and Metformin Extended-Release Tablets Production Value by Production Technology (2021-2032)
6.3.3 World Dapagliflozin and Metformin Extended-Release Tablets Average Price by Production Technology (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Dapagliflozin and Metformin Extended-Release Tablets Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Extended-release tablet
7.2.2 Conventional Tablet
7.3 Market Segment by Dosage Form
7.3.1 World Dapagliflozin and Metformin Extended-Release Tablets Production by Dosage Form (2021-2032)
7.3.2 World Dapagliflozin and Metformin Extended-Release Tablets Production Value by Dosage Form (2021-2032)
7.3.3 World Dapagliflozin and Metformin Extended-Release Tablets Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Dapagliflozin and Metformin Extended-Release Tablets Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Type 2 Diabetes
8.2.2 Weight Management
8.2.3 Cardiovascular
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Dapagliflozin and Metformin Extended-Release Tablets Production by Application (2021-2032)
8.3.2 World Dapagliflozin and Metformin Extended-Release Tablets Production Value by Application (2021-2032)
8.3.3 World Dapagliflozin and Metformin Extended-Release Tablets Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 AstraZeneca
9.1.1 AstraZeneca Details
9.1.2 AstraZeneca Major Business
9.1.3 AstraZeneca Dapagliflozin and Metformin Extended-Release Tablets Product and Services
9.1.4 AstraZeneca Dapagliflozin and Metformin Extended-Release Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 AstraZeneca Recent Developments/Updates
9.1.6 AstraZeneca Competitive Strengths & Weaknesses
9.2 Merck
9.2.1 Merck Details
9.2.2 Merck Major Business
9.2.3 Merck Dapagliflozin and Metformin Extended-Release Tablets Product and Services
9.2.4 Merck Dapagliflozin and Metformin Extended-Release Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Merck Recent Developments/Updates
9.2.6 Merck Competitive Strengths & Weaknesses
9.3 Pfizer
9.3.1 Pfizer Details
9.3.2 Pfizer Major Business
9.3.3 Pfizer Dapagliflozin and Metformin Extended-Release Tablets Product and Services
9.3.4 Pfizer Dapagliflozin and Metformin Extended-Release Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Pfizer Recent Developments/Updates
9.3.6 Pfizer Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Dapagliflozin and Metformin Extended-Release Tablets Industry Chain
10.2 Dapagliflozin and Metformin Extended-Release Tablets Upstream Analysis
10.2.1 Dapagliflozin and Metformin Extended-Release Tablets Core Raw Materials
10.2.2 Main Manufacturers of Dapagliflozin and Metformin Extended-Release Tablets Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Dapagliflozin and Metformin Extended-Release Tablets Production Mode
10.6 Dapagliflozin and Metformin Extended-Release Tablets Procurement Model
10.7 Dapagliflozin and Metformin Extended-Release Tablets Industry Sales Model and Sales Channels
10.7.1 Dapagliflozin and Metformin Extended-Release Tablets Sales Model
10.7.2 Dapagliflozin and Metformin Extended-Release Tablets Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Dapagliflozin and Metformin Extended-Release Tablets Introduction
1.2 World Dapagliflozin and Metformin Extended-Release Tablets Supply & Forecast
1.2.1 World Dapagliflozin and Metformin Extended-Release Tablets Production Value (2021 & 2025 & 2032)
1.2.2 World Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2032)
1.2.3 World Dapagliflozin and Metformin Extended-Release Tablets Pricing Trends (2021-2032)
1.3 World Dapagliflozin and Metformin Extended-Release Tablets Production by Region (Based on Production Site)
1.3.1 World Dapagliflozin and Metformin Extended-Release Tablets Production Value by Region (2021-2032)
1.3.2 World Dapagliflozin and Metformin Extended-Release Tablets Production by Region (2021-2032)
1.3.3 World Dapagliflozin and Metformin Extended-Release Tablets Average Price by Region (2021-2032)
1.3.4 North America Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2032)
1.3.5 Europe Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2032)
1.3.6 China Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2032)
1.3.7 Japan Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2032)
1.3.8 India Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Dapagliflozin and Metformin Extended-Release Tablets Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Dapagliflozin and Metformin Extended-Release Tablets Major Market Trends
2 DEMAND SUMMARY
2.1 World Dapagliflozin and Metformin Extended-Release Tablets Demand (2021-2032)
2.2 World Dapagliflozin and Metformin Extended-Release Tablets Consumption by Region
2.2.1 World Dapagliflozin and Metformin Extended-Release Tablets Consumption by Region (2021-2026)
2.2.2 World Dapagliflozin and Metformin Extended-Release Tablets Consumption Forecast by Region (2027-2032)
2.3 United States Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
2.4 China Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
2.5 Europe Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
2.6 Japan Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
2.7 South Korea Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
2.8 ASEAN Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
2.9 India Dapagliflozin and Metformin Extended-Release Tablets Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Dapagliflozin and Metformin Extended-Release Tablets Production Value by Manufacturer (2021-2026)
3.2 World Dapagliflozin and Metformin Extended-Release Tablets Production by Manufacturer (2021-2026)
3.3 World Dapagliflozin and Metformin Extended-Release Tablets Average Price by Manufacturer (2021-2026)
3.4 Dapagliflozin and Metformin Extended-Release Tablets Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Dapagliflozin and Metformin Extended-Release Tablets Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Dapagliflozin and Metformin Extended-Release Tablets in 2025
3.5.3 Global Concentration Ratios (CR8) for Dapagliflozin and Metformin Extended-Release Tablets in 2025
3.6 Dapagliflozin and Metformin Extended-Release Tablets Market: Overall Company Footprint Analysis
3.6.1 Dapagliflozin and Metformin Extended-Release Tablets Market: Region Footprint
3.6.2 Dapagliflozin and Metformin Extended-Release Tablets Market: Company Product Type Footprint
3.6.3 Dapagliflozin and Metformin Extended-Release Tablets Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Production Value Comparison
4.1.1 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Production Comparison
4.2.1 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Consumption Comparison
4.3.1 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Dapagliflozin and Metformin Extended-Release Tablets Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Dapagliflozin and Metformin Extended-Release Tablets Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Dapagliflozin and Metformin Extended-Release Tablets Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Dapagliflozin and Metformin Extended-Release Tablets Production Value (2021-2026)
4.4.3 United States Based Manufacturers Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2026)
4.5 China Based Dapagliflozin and Metformin Extended-Release Tablets Manufacturers and Market Share
4.5.1 China Based Dapagliflozin and Metformin Extended-Release Tablets Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Dapagliflozin and Metformin Extended-Release Tablets Production Value (2021-2026)
4.5.3 China Based Manufacturers Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2026)
4.6 Rest of World Based Dapagliflozin and Metformin Extended-Release Tablets Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Dapagliflozin and Metformin Extended-Release Tablets Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-Release Tablets Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-Release Tablets Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Dapagliflozin and Metformin Extended-Release Tablets Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 10mg/1000mg
5.2.2 5mg + 500mg
5.3 Market Segment by Type
5.3.1 World Dapagliflozin and Metformin Extended-Release Tablets Production by Type (2021-2032)
5.3.2 World Dapagliflozin and Metformin Extended-Release Tablets Production Value by Type (2021-2032)
5.3.3 World Dapagliflozin and Metformin Extended-Release Tablets Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
6.1 World Dapagliflozin and Metformin Extended-Release Tablets Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Production Technology
6.2.1 Innovator
6.2.2 Generic
6.3 Market Segment by Production Technology
6.3.1 World Dapagliflozin and Metformin Extended-Release Tablets Production by Production Technology (2021-2032)
6.3.2 World Dapagliflozin and Metformin Extended-Release Tablets Production Value by Production Technology (2021-2032)
6.3.3 World Dapagliflozin and Metformin Extended-Release Tablets Average Price by Production Technology (2021-2032)
7 MARKET ANALYSIS BY DOSAGE FORM
7.1 World Dapagliflozin and Metformin Extended-Release Tablets Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dosage Form
7.2.1 Extended-release tablet
7.2.2 Conventional Tablet
7.3 Market Segment by Dosage Form
7.3.1 World Dapagliflozin and Metformin Extended-Release Tablets Production by Dosage Form (2021-2032)
7.3.2 World Dapagliflozin and Metformin Extended-Release Tablets Production Value by Dosage Form (2021-2032)
7.3.3 World Dapagliflozin and Metformin Extended-Release Tablets Average Price by Dosage Form (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Dapagliflozin and Metformin Extended-Release Tablets Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Type 2 Diabetes
8.2.2 Weight Management
8.2.3 Cardiovascular
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Dapagliflozin and Metformin Extended-Release Tablets Production by Application (2021-2032)
8.3.2 World Dapagliflozin and Metformin Extended-Release Tablets Production Value by Application (2021-2032)
8.3.3 World Dapagliflozin and Metformin Extended-Release Tablets Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 AstraZeneca
9.1.1 AstraZeneca Details
9.1.2 AstraZeneca Major Business
9.1.3 AstraZeneca Dapagliflozin and Metformin Extended-Release Tablets Product and Services
9.1.4 AstraZeneca Dapagliflozin and Metformin Extended-Release Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 AstraZeneca Recent Developments/Updates
9.1.6 AstraZeneca Competitive Strengths & Weaknesses
9.2 Merck
9.2.1 Merck Details
9.2.2 Merck Major Business
9.2.3 Merck Dapagliflozin and Metformin Extended-Release Tablets Product and Services
9.2.4 Merck Dapagliflozin and Metformin Extended-Release Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Merck Recent Developments/Updates
9.2.6 Merck Competitive Strengths & Weaknesses
9.3 Pfizer
9.3.1 Pfizer Details
9.3.2 Pfizer Major Business
9.3.3 Pfizer Dapagliflozin and Metformin Extended-Release Tablets Product and Services
9.3.4 Pfizer Dapagliflozin and Metformin Extended-Release Tablets Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Pfizer Recent Developments/Updates
9.3.6 Pfizer Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Dapagliflozin and Metformin Extended-Release Tablets Industry Chain
10.2 Dapagliflozin and Metformin Extended-Release Tablets Upstream Analysis
10.2.1 Dapagliflozin and Metformin Extended-Release Tablets Core Raw Materials
10.2.2 Main Manufacturers of Dapagliflozin and Metformin Extended-Release Tablets Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Dapagliflozin and Metformin Extended-Release Tablets Production Mode
10.6 Dapagliflozin and Metformin Extended-Release Tablets Procurement Model
10.7 Dapagliflozin and Metformin Extended-Release Tablets Industry Sales Model and Sales Channels
10.7.1 Dapagliflozin and Metformin Extended-Release Tablets Sales Model
10.7.2 Dapagliflozin and Metformin Extended-Release Tablets Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Region (2021-2026) & (USD Million)
Table 3. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Region (2027-2032) & (USD Million)
Table 4. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Region (2021-2026)
Table 5. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Region (2027-2032)
Table 6. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Region (2021-2026) & (Units)
Table 7. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Region (2027-2032) & (Units)
Table 8. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Region (2021-2026)
Table 9. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Region (2027-2032)
Table 10. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Dapagliflozin and Metformin Extended-ReleaseTablets Major Market Trends
Table 13. World Dapagliflozin and Metformin Extended-ReleaseTablets Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Dapagliflozin and Metformin Extended-ReleaseTablets Consumption by Region (2021-2026) & (Units)
Table 15. World Dapagliflozin and Metformin Extended-ReleaseTablets Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Dapagliflozin and Metformin Extended-ReleaseTablets Producers in 2025
Table 18. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Dapagliflozin and Metformin Extended-ReleaseTablets Producers in 2025
Table 20. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Dapagliflozin and Metformin Extended-ReleaseTablets Company Evaluation Quadrant
Table 22. World Dapagliflozin and Metformin Extended-ReleaseTablets Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Dapagliflozin and Metformin Extended-ReleaseTablets Production Site of Key Manufacturer
Table 24. Dapagliflozin and Metformin Extended-ReleaseTablets Market: Company Product Type Footprint
Table 25. Dapagliflozin and Metformin Extended-ReleaseTablets Market: Company Product Application Footprint
Table 26. Dapagliflozin and Metformin Extended-ReleaseTablets Competitive Factors
Table 27. Dapagliflozin and Metformin Extended-ReleaseTablets New Entrant and Capacity Expansion Plans
Table 28. Dapagliflozin and Metformin Extended-ReleaseTablets Mergers & Acquisitions Activity
Table 29. United States VS China Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Dapagliflozin and Metformin Extended-ReleaseTablets Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Dapagliflozin and Metformin Extended-ReleaseTablets Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Dapagliflozin and Metformin Extended-ReleaseTablets Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share (2021-2026)
Table 37. China Based Dapagliflozin and Metformin Extended-ReleaseTablets Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share (2021-2026)
Table 42. Rest of World Based Dapagliflozin and Metformin Extended-ReleaseTablets Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share (2021-2026)
Table 47. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Type (2021-2026) & (Units)
Table 49. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Type (2027-2032) & (Units)
Table 50. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Type (2021-2026) & (USD Million)
Table 51. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Type (2027-2032) & (USD Million)
Table 52. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 55. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Production Technology (2021-2026) & (Units)
Table 56. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Production Technology (2027-2032) & (Units)
Table 57. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Production Technology (2021-2026) & (USD Million)
Table 58. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Production Technology (2027-2032) & (USD Million)
Table 59. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 60. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 61. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Dosage Form (2021-2026) & (Units)
Table 63. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Dosage Form (2027-2032) & (Units)
Table 64. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 67. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 68. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Application (2021-2026) & (Units)
Table 70. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Application (2027-2032) & (Units)
Table 71. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Application (2021-2026) & (USD Million)
Table 72. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Application (2027-2032) & (USD Million)
Table 73. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Application (2027-2032) & (US$/Unit)
Table 75. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 76. AstraZeneca Major Business
Table 77. AstraZeneca Dapagliflozin and Metformin Extended-ReleaseTablets Product and Services
Table 78. AstraZeneca Dapagliflozin and Metformin Extended-ReleaseTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. AstraZeneca Recent Developments/Updates
Table 80. AstraZeneca Competitive Strengths & Weaknesses
Table 81. Merck Basic Information, Manufacturing Base and Competitors
Table 82. Merck Major Business
Table 83. Merck Dapagliflozin and Metformin Extended-ReleaseTablets Product and Services
Table 84. Merck Dapagliflozin and Metformin Extended-ReleaseTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Merck Recent Developments/Updates
Table 86. Merck Competitive Strengths & Weaknesses
Table 87. Pfizer Basic Information, Manufacturing Base and Competitors
Table 88. Pfizer Major Business
Table 89. Pfizer Dapagliflozin and Metformin Extended-ReleaseTablets Product and Services
Table 90. Pfizer Dapagliflozin and Metformin Extended-ReleaseTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Pfizer Recent Developments/Updates
Table 92. Pfizer Competitive Strengths & Weaknesses
Table 93. Global Key Players of Dapagliflozin and Metformin Extended-ReleaseTablets Upstream (Raw Materials)
Table 94. Global Dapagliflozin and Metformin Extended-ReleaseTablets Typical Customers
Table 95. Dapagliflozin and Metformin Extended-ReleaseTablets Typical Distributors
Table 1. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Region (2021-2026) & (USD Million)
Table 3. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Region (2027-2032) & (USD Million)
Table 4. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Region (2021-2026)
Table 5. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Region (2027-2032)
Table 6. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Region (2021-2026) & (Units)
Table 7. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Region (2027-2032) & (Units)
Table 8. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Region (2021-2026)
Table 9. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Region (2027-2032)
Table 10. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Dapagliflozin and Metformin Extended-ReleaseTablets Major Market Trends
Table 13. World Dapagliflozin and Metformin Extended-ReleaseTablets Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Dapagliflozin and Metformin Extended-ReleaseTablets Consumption by Region (2021-2026) & (Units)
Table 15. World Dapagliflozin and Metformin Extended-ReleaseTablets Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Dapagliflozin and Metformin Extended-ReleaseTablets Producers in 2025
Table 18. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Dapagliflozin and Metformin Extended-ReleaseTablets Producers in 2025
Table 20. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Dapagliflozin and Metformin Extended-ReleaseTablets Company Evaluation Quadrant
Table 22. World Dapagliflozin and Metformin Extended-ReleaseTablets Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Dapagliflozin and Metformin Extended-ReleaseTablets Production Site of Key Manufacturer
Table 24. Dapagliflozin and Metformin Extended-ReleaseTablets Market: Company Product Type Footprint
Table 25. Dapagliflozin and Metformin Extended-ReleaseTablets Market: Company Product Application Footprint
Table 26. Dapagliflozin and Metformin Extended-ReleaseTablets Competitive Factors
Table 27. Dapagliflozin and Metformin Extended-ReleaseTablets New Entrant and Capacity Expansion Plans
Table 28. Dapagliflozin and Metformin Extended-ReleaseTablets Mergers & Acquisitions Activity
Table 29. United States VS China Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Dapagliflozin and Metformin Extended-ReleaseTablets Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Dapagliflozin and Metformin Extended-ReleaseTablets Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Dapagliflozin and Metformin Extended-ReleaseTablets Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share (2021-2026)
Table 37. China Based Dapagliflozin and Metformin Extended-ReleaseTablets Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share (2021-2026)
Table 42. Rest of World Based Dapagliflozin and Metformin Extended-ReleaseTablets Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share (2021-2026)
Table 47. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Type (2021-2026) & (Units)
Table 49. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Type (2027-2032) & (Units)
Table 50. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Type (2021-2026) & (USD Million)
Table 51. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Type (2027-2032) & (USD Million)
Table 52. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 55. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Production Technology (2021-2026) & (Units)
Table 56. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Production Technology (2027-2032) & (Units)
Table 57. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Production Technology (2021-2026) & (USD Million)
Table 58. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Production Technology (2027-2032) & (USD Million)
Table 59. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 60. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 61. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 62. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Dosage Form (2021-2026) & (Units)
Table 63. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Dosage Form (2027-2032) & (Units)
Table 64. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Dosage Form (2021-2026) & (USD Million)
Table 65. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Dosage Form (2027-2032) & (USD Million)
Table 66. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 67. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 68. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Application (2021-2026) & (Units)
Table 70. World Dapagliflozin and Metformin Extended-ReleaseTablets Production by Application (2027-2032) & (Units)
Table 71. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Application (2021-2026) & (USD Million)
Table 72. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Application (2027-2032) & (USD Million)
Table 73. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Application (2027-2032) & (US$/Unit)
Table 75. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 76. AstraZeneca Major Business
Table 77. AstraZeneca Dapagliflozin and Metformin Extended-ReleaseTablets Product and Services
Table 78. AstraZeneca Dapagliflozin and Metformin Extended-ReleaseTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. AstraZeneca Recent Developments/Updates
Table 80. AstraZeneca Competitive Strengths & Weaknesses
Table 81. Merck Basic Information, Manufacturing Base and Competitors
Table 82. Merck Major Business
Table 83. Merck Dapagliflozin and Metformin Extended-ReleaseTablets Product and Services
Table 84. Merck Dapagliflozin and Metformin Extended-ReleaseTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Merck Recent Developments/Updates
Table 86. Merck Competitive Strengths & Weaknesses
Table 87. Pfizer Basic Information, Manufacturing Base and Competitors
Table 88. Pfizer Major Business
Table 89. Pfizer Dapagliflozin and Metformin Extended-ReleaseTablets Product and Services
Table 90. Pfizer Dapagliflozin and Metformin Extended-ReleaseTablets Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Pfizer Recent Developments/Updates
Table 92. Pfizer Competitive Strengths & Weaknesses
Table 93. Global Key Players of Dapagliflozin and Metformin Extended-ReleaseTablets Upstream (Raw Materials)
Table 94. Global Dapagliflozin and Metformin Extended-ReleaseTablets Typical Customers
Table 95. Dapagliflozin and Metformin Extended-ReleaseTablets Typical Distributors
LIST OF FIGURES
Figure 1. Dapagliflozin and Metformin Extended-ReleaseTablets Picture
Figure 2. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2032) & (Units)
Figure 5. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price (2021-2032) & (US$/Unit)
Figure 6. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Region (2021-2032)
Figure 7. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Region (2021-2032)
Figure 8. North America Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2032) & (Units)
Figure 9. Europe Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2032) & (Units)
Figure 10. China Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2032) & (Units)
Figure 11. Japan Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2032) & (Units)
Figure 12. India Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2032) & (Units)
Figure 13. Dapagliflozin and Metformin Extended-ReleaseTablets Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 16. World Dapagliflozin and Metformin Extended-ReleaseTablets Consumption Market Share by Region (2021-2032)
Figure 17. United States Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 18. China Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 19. Europe Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 20. Japan Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 21. South Korea Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 22. ASEAN Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 23. India Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Dapagliflozin and Metformin Extended-ReleaseTablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Dapagliflozin and Metformin Extended-ReleaseTablets Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Dapagliflozin and Metformin Extended-ReleaseTablets Markets in 2025
Figure 27. United States VS China: Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Dapagliflozin and Metformin Extended-ReleaseTablets Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share 2025
Figure 31. China Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share 2025
Figure 33. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Type in 2025
Figure 35. 10mg/1000mg
Figure 36. 5mg + 500mg
Figure 37. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Type (2021-2032)
Figure 38. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Type (2021-2032)
Figure 39. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 41. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Production Technology in 2025
Figure 42. Innovator
Figure 43. Generic
Figure 44. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Production Technology (2021-2032)
Figure 45. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Production Technology (2021-2032)
Figure 46. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 47. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 48. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Dosage Form in 2025
Figure 49. Extended-release tablet
Figure 50. ConventionalTablet
Figure 51. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Dosage Form (2021-2032)
Figure 52. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Dosage Form (2021-2032)
Figure 53. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 54. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Application in 2025
Figure 56. Type 2 Diabetes
Figure 57. Weight Management
Figure 58. Cardiovascular
Figure 59. Others
Figure 60. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Application (2021-2032)
Figure 61. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Application (2021-2032)
Figure 62. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Dapagliflozin and Metformin Extended-ReleaseTablets Industry Chain
Figure 64. Dapagliflozin and Metformin Extended-ReleaseTablets Procurement Model
Figure 65. Dapagliflozin and Metformin Extended-ReleaseTablets Sales Model
Figure 66. Dapagliflozin and Metformin Extended-ReleaseTablets Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
Figure 1. Dapagliflozin and Metformin Extended-ReleaseTablets Picture
Figure 2. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2032) & (Units)
Figure 5. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price (2021-2032) & (US$/Unit)
Figure 6. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Region (2021-2032)
Figure 7. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Region (2021-2032)
Figure 8. North America Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2032) & (Units)
Figure 9. Europe Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2032) & (Units)
Figure 10. China Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2032) & (Units)
Figure 11. Japan Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2032) & (Units)
Figure 12. India Dapagliflozin and Metformin Extended-ReleaseTablets Production (2021-2032) & (Units)
Figure 13. Dapagliflozin and Metformin Extended-ReleaseTablets Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 16. World Dapagliflozin and Metformin Extended-ReleaseTablets Consumption Market Share by Region (2021-2032)
Figure 17. United States Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 18. China Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 19. Europe Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 20. Japan Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 21. South Korea Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 22. ASEAN Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 23. India Dapagliflozin and Metformin Extended-ReleaseTablets Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Dapagliflozin and Metformin Extended-ReleaseTablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Dapagliflozin and Metformin Extended-ReleaseTablets Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Dapagliflozin and Metformin Extended-ReleaseTablets Markets in 2025
Figure 27. United States VS China: Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Dapagliflozin and Metformin Extended-ReleaseTablets Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share 2025
Figure 31. China Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share 2025
Figure 33. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Type in 2025
Figure 35. 10mg/1000mg
Figure 36. 5mg + 500mg
Figure 37. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Type (2021-2032)
Figure 38. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Type (2021-2032)
Figure 39. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 41. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Production Technology in 2025
Figure 42. Innovator
Figure 43. Generic
Figure 44. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Production Technology (2021-2032)
Figure 45. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Production Technology (2021-2032)
Figure 46. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 47. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 48. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Dosage Form in 2025
Figure 49. Extended-release tablet
Figure 50. ConventionalTablet
Figure 51. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Dosage Form (2021-2032)
Figure 52. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Dosage Form (2021-2032)
Figure 53. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 54. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Application in 2025
Figure 56. Type 2 Diabetes
Figure 57. Weight Management
Figure 58. Cardiovascular
Figure 59. Others
Figure 60. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Market Share by Application (2021-2032)
Figure 61. World Dapagliflozin and Metformin Extended-ReleaseTablets Production Value Market Share by Application (2021-2032)
Figure 62. World Dapagliflozin and Metformin Extended-ReleaseTablets Average Price by Application (2021-2032) & (US$/Unit)
Figure 63. Dapagliflozin and Metformin Extended-ReleaseTablets Industry Chain
Figure 64. Dapagliflozin and Metformin Extended-ReleaseTablets Procurement Model
Figure 65. Dapagliflozin and Metformin Extended-ReleaseTablets Sales Model
Figure 66. Dapagliflozin and Metformin Extended-ReleaseTablets Sales Channels, Direct Sales, and Distribution
Figure 67. Methodology
Figure 68. Research Process and Data Source
